News

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...
Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...
Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...
NIH's new strategy emphasizes transparency, prioritizes urgent health needs, and shifts focus to domestic research and ...
Expanded approval of Wegovy was based on results from the Phase III ESSENCE trial (NCT04822181), which demonstrated ...
Vanda Pharmaceuticals won a legal battle as a federal court overturned the FDA's rejection of Hetlioz for jet lag disorder, ...
An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...
Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...
Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...
What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...
How a layered approach—tapping new avenues from earned media—can go a long way in boosting the brand engagement interplay ...
As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find ways to ...